PACLITAXEL POLIGLUMEX AND CARBOPLATIN AS FIRST-LINE THERAPY IN OVARIAN, PERITONEAL OR FALLOPIAN TUBE CANCER: A PHASE I AND FEASIBILITY TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP

PURPOSE: To estimate the maximum tolerated dose (MTD) of paclitaxel poliglumex (PPX) in combination with carboplatin in patients with chemotherapy-naive ovarian, primary peritoneal or fallopian tube cancer, and to assess the feasibility of administering multiple cycles of this regimen. METHODS: The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Morgan, Mark A., Darcy, Kathleen M., Rose, Peter G., DeGeest, Koen, Bookman, Michael A., Aikins, James K., Sill, Michael W., Mannel, Robert S., Allievi, Cecilia, Egorin, Merrill J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2577579/
https://ncbi.nlm.nih.gov/pubmed/18597837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2008.05.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados